BATS:BLUE   bluebird bio, Inc.
FDA non-approved therapy, price drops. Might have some pullback at resistance and might go deeper if no good news comes to save the stock.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.